Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2018, Article ID 8267560, 10 pages
https://doi.org/10.1155/2018/8267560
Research Article

Noninvasive Real-Time Characterization of Renal Clearance Kinetics in Diabetic Mice after Receiving Danshensu Treatment

1Department of Health Technology and Informatics, Hong Kong Polytechnic University, Kowloon, Hong Kong
2School of Biomedical Sciences, Chinese University of Hong Kong, New Territories, Hong Kong
3School of Medical Science and Menzies Health Institute Queensland, Griffith University, Gold Coast, Australia

Correspondence should be addressed to Andrew C. Bulmer; ua.ude.htiffirg@remlub.a and Christopher W. K. Lai; kh.ude.uylop@ial.sirhc

Received 17 August 2017; Revised 28 November 2017; Accepted 31 December 2017; Published 12 February 2018

Academic Editor: Evangelia Dounousi

Copyright © 2018 Lei Gao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Davì, A. Falco, and C. Patrono, “Lipid peroxidation in diabetes mellitus,” Antioxidants & Redox Signaling, vol. 7, no. 1-2, pp. 256–268, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. M. P. Mattson, “Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders,” Experimental Gerontology, vol. 44, no. 10, pp. 625–633, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. F. B. Stentz, G. E. Umpierrez, R. Cuervo, and A. E. Kitabchi, “Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises,” Diabetes, vol. 53, no. 8, pp. 2079–2086, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Kubo, Y. Kiyohara, I. Kato et al., “Effect of hyperinsulinemia on renal function in a general Japanese population: the Hisayama study,” Kidney International, vol. 55, no. 6, pp. 2450–2456, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Fliser, G. Pacini, R. Engelleiter et al., “Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease,” Kidney International, vol. 53, no. 5, pp. 1343–1347, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Yoh, A. Hirayama, K. Ishizaki et al., “Hyperglycemia induces oxidative and nitrosative stress and increases renal functional impairment in Nrf2-deficient mice,” Genes to Cells, vol. 13, no. 11, pp. 1159–1170, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Son, J. H. Lee, Y.-K. Cheong, H.-T. Chung, and H.-O. Pae, “Antidiabetic potential of the heme oxygenase-1 inducer curcumin analogues,” BioMed Research International, vol. 2013, Article ID 918039, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Liu, L. Wang, X. Y. Tian et al., “Unconjugated bilirubin mediates heme oxygenase-1–induced vascular benefits in diabetic mice,” Diabetes, vol. 64, no. 5, pp. 1564–1575, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. S. S. Han, K. Y. Na, D.-W. Chae, Y. S. Kim, S. Kim, and H. J. Chin, “High serum bilirubin is associated with the reduced risk of diabetes mellitus and diabetic nephropathy,” The Tohoku Journal of Experimental Medicine, vol. 221, no. 2, pp. 133–140, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Li, F. Song, L.-R. Duan et al., “Paeonol and danshensu combination attenuates apoptosis in myocardial infarcted rats by inhibiting oxidative stress: roles of Nrf2/HO-1 and PI3K/Akt pathway,” Scientific Reports, vol. 6, no. 1, article 23693, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Chan, S. H. Chui, D. Y. L. Wong, W. Y. Ha, C. L. Chan, and R. N. S. Wong, “Protective effects of Danshensu from the aqueous extract of Salvia miltiorrhiza (Danshen) against homocysteine-induced endothelial dysfunction,” Life Sciences, vol. 75, no. 26, pp. 3157–3171, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Tang, M. Wang, C. Chen, X. Le, S. Sun, and Y. Yin, “Cardiovascular protection with danshensu in spontaneously hypertensive rats,” Biological & Pharmaceutical Bulletin, vol. 34, no. 10, pp. 1596–1601, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Chen, Z. Liu, F. Zhou et al., “Evaluating pharmacological effects of two major components of Shuangdan oral liquid: role of Danshensu and Paeonol in diabetic nephropathy rat,” Biomolecules & Therapeutics, vol. 24, no. 5, pp. 536–542, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Xu, P. Shen, Y. Bi et al., “Danshen injection ameliorates STZ-induced diabetic nephropathy in association with suppression of oxidative stress, pro-inflammatory factors and fibrosis,” International Immunopharmacology, vol. 38, pp. 385–394, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Tang, M. Wang, X. Le et al., “Antioxidant and cardioprotective effects of Danshensu (3-(3, 4-dihydroxyphenyl)-2-hydroxy-propanoic acid from Salvia miltiorrhiza) on isoproterenol-induced myocardial hypertrophy in rats,” Phytomedicine, vol. 18, no. 12, pp. 1024–1030, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Liu, H. M. Shen, and C. N. Ong, “Role of intracellular thiol depletion, mitochondrial dysfunction and reactive oxygen species in Salvia Miltiorrhiza-induced apoptosis in human hepatoma HepG2 cells,” Life Sciences, vol. 69, no. 16, pp. 1833–1850, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Wang, H. Song, J. Yue, J. Li, Y. B. Hou, and J. L. Deng, “Rheum officinale (a traditional Chinese medicine) for chronic kidney disease,” Cochrane Database of Systematic Reviews, 2012. View at Publisher · View at Google Scholar
  18. G.-R. Zhao, H.-M. Zhang, T.-X. Ye et al., “Characterization of the radical scavenging and antioxidant activities of danshensu and salvianolic acid B,” Food and Chemical Toxicology, vol. 46, no. 1, pp. 73–81, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Ding, G.-R. Zhao, T.-X. Ye, Y.-J. Yuan, and Z.-X. Guo, “Salvia miltiorrhiza protects endothelial cells against oxidative stress,” The Journal of Alternative and Complementary Medicine, vol. 12, no. 1, pp. 5-6, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. V. Ntziachristos and D. Razansky, “Molecular imaging by means of multispectral optoacoustic tomography (MSOT),” Chemical Reviews, vol. 110, no. 5, pp. 2783–2794, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Weissleder and M. J. Pittet, “Imaging in the era of molecular oncology,” Nature, vol. 452, no. 7187, pp. 580–589, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Buehler, E. Herzog, D. Razansky, and V. Ntziachristos, “Video rate optoacoustic tomography of mouse kidney perfusion,” Optics Letters, vol. 35, no. 14, pp. 2475–2477, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. M.-L. Li, O. J-T, X. Xie et al., “Simultaneous molecular and hypoxia imaging of brain tumors in vivo using spectroscopic photoacoustic tomography,” Proceedings of the IEEE, vol. 96, no. 3, pp. 481–489, 2008. View at Google Scholar
  24. S. J. Peterson, D. H. Kim, M. Li et al., “The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice,” Journal of Lipid Research, vol. 50, no. 7, pp. 1293–1304, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. S. J. Peterson, G. Drummond, D. H. Kim et al., “L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice,” Journal of Lipid Research, vol. 49, no. 8, pp. 1658–1669, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. D. H. Kim, A. P. Burgess, M. Li et al., “Heme oxygenase-mediated increases in adiponectin decrease fat content and inflammatory cytokines tumor necrosis factor-α and interleukin-6 in Zucker rats and reduce adipogenesis in human mesenchymal stem cells,” Journal of Pharmacology and Experimental Therapeutics, vol. 325, no. 3, pp. 833–840, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. N. G. Abraham and A. Kappas, “Heme oxygenase and the cardiovascular–renal system,” Free Radical Biology and Medicine, vol. 39, no. 1, pp. 1–25, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. T. W. Sedlak, M. Saleh, D. S. Higginson, B. D. Paul, K. R. Juluri, and S. H. Snyder, “Bilirubin and glutathione have complementary antioxidant and cytoprotective roles,” Proceedings of the National Academy of Sciences, vol. 106, no. 13, pp. 5171–5176, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Ziberna, M. Martelanc, M. Franko, and S. Passamonti, “Bilirubin is an endogenous antioxidant in human vascular endothelial cells,” Scientific Reports, vol. 6, no. 1, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Tanaka, M. Fukui, H. Okada et al., “Low serum bilirubin concentration is a predictor of chronic kidney disease,” Atherosclerosis, vol. 234, no. 2, pp. 421–425, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Mashitani, Y. Hayashino, S. Okamura, S. Tsujii, and H. Ishii, “Correlations between serum bilirubin levels and diabetic nephropathy progression among Japanese type 2 diabetic patients: a prospective cohort study (Diabetes Distress and Care Registry at Tenri [DDCRT 5]),” Diabetes Care, vol. 37, no. 1, pp. 252–258, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. H. J. Chin, H. J. Cho, T. W. Lee et al., “The mildly elevated serum bilirubin level is negatively associated with the incidence of end stage renal disease in patients with IgA nephropathy,” Journal of Korean Medical Science, vol. 24, no. Supplement 1, pp. S22–SS9, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. A.-C. Boon, A. C. Bulmer, J. S. Coombes, and R. G. Fassett, “Circulating bilirubin and defense against kidney disease and cardiovascular mortality: mechanisms contributing to protection in clinical investigations,” American Journal of Physiology-Renal Physiology, vol. 307, no. 2, pp. F123–F136, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. W. K. Leung, L. Gao, P. M. Siu, and C. W. Lai, “Diabetic nephropathy and endothelial dysfunction: current and future therapies, and emerging of vascular imaging for preclinical renal-kinetic study,” Life Sciences, vol. 166, pp. 121–130, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. K. A. Nath, “Heme oxygenase-1 and acute kidney injury,” Current Opinion in Nephrology and Hypertension, vol. 23, no. 1, pp. 17–24, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. K. P. Hummel, M. M. Dickie, and D. L. Coleman, “Diabetes, a new mutafton in the mouse,” Science, vol. 153, no. 3740, pp. 1127-1128, 1966. View at Publisher · View at Google Scholar
  37. J. Wang, Z. Ma, Z. Hong, and J. Song, “Tissue distribution in mice of danshensu from sodium danshensu and Salvia miltiorrhiza injection,” Zhongguo Zhong Yao Za Zhi, vol. 36, no. 11, pp. 1516–1518, 2011. View at Google Scholar
  38. L. Scarfe, A. Rak-Raszewska, S. Geraci et al., “Measures of kidney function by minimally invasive techniques correlate with histological glomerular damage in SCID mice with adriamycin-induced nephropathy,” Scientific Reports, vol. 5, no. 1, article 13601, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Taruttis, S. Morscher, N. C. Burton, D. Razansky, and V. Ntziachristos, “Fast multispectral optoacoustic tomography (MSOT) for dynamic imaging of pharmacokinetics and biodistribution in multiple organs,” PLoS One, vol. 7, no. 1, article e30491, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. I. Loeffler, C. Rüster, S. Franke, M. Liebisch, and G. Wolf, “Erythropoietin ameliorates podocyte injury in advanced diabetic nephropathy in the db/db mouse,” American Journal of Physiology-Renal Physiology, vol. 305, no. 6, pp. F911–F918, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Fujii, T. Inoguchi, S. Sasaki et al., “Bilirubin and biliverdin protect rodents against diabetic nephropathy by downregulating NAD(P)H oxidase,” Kidney International, vol. 78, no. 9, pp. 905–919, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. S. M. Hofmann, H.-J. Dong, Z. Li et al., “Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse,” Diabetes, vol. 51, no. 7, pp. 2082–2089, 2002. View at Publisher · View at Google Scholar
  43. S. Guan, J. Ma, Y. Zhang et al., “Danshen (Salvia miltiorrhiza) injection suppresses kidney injury induced by iron overload in mice,” PLoS One, vol. 8, no. 9, article e74318, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. Guan, W. X-X, J.-L. Duan et al., “Effects and mechanism of combination of Rhein and Danshensu in the treatment of chronic kidney disease,” The American Journal of Chinese Medicine, vol. 43, no. 07, pp. 1381–1400, 2015. View at Publisher · View at Google Scholar · View at Scopus
  45. C. M. C. Mels, H. W. Huisman, W. Smith et al., “The relationship of nitric oxide synthesis capacity, oxidative stress, and albumin-to-creatinine ratio in black and white men: the SABPA study,” Age, vol. 38, no. 1, p. 9, 2016. View at Publisher · View at Google Scholar · View at Scopus
  46. L.-L. Pan, X.-H. Liu, Y.-L. Jia et al., “A novel compound derived from danshensu inhibits apoptosis via upregulation of heme oxygenase-1 expression in SH-SY5Y cells,” Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 1830, no. 4, pp. 2861–2871, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Hu, G. Wei, M. Xi et al., “Synergistic cardioprotective effects of Danshensu and hydroxysafflor yellow A against myocardial ischemia-reperfusion injury are mediated through the Akt/Nrf2/HO-1 pathway,” International Journal of Molecular Medicine, vol. 38, no. 1, pp. 83–94, 2016. View at Publisher · View at Google Scholar · View at Scopus
  48. A. S. Bastos, D. T. Graves, L. APdM et al., “Lipid peroxidation is associated with the severity of periodontal disease and local inflammatory markers in patients with type 2 diabetes,” The Journal of Clinical Endocrinology & Metabolism, vol. 97, no. 8, pp. E1353–E1362, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. B. Halliwell, “Oral inflammation and reactive species: a missed opportunity?” Oral Diseases, vol. 6, no. 3, pp. 136-137, 2000. View at Google Scholar
  50. A. Negre-Salvayre, C. Coatrieux, C. Ingueneau, and R. Salvayre, “Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors,” British Journal of Pharmacology, vol. 153, no. 1, pp. 6–20, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. R. Soundravally, S. Hoti, S. A. Patil et al., “Association between proinflammatory cytokines and lipid peroxidation in patients with severe dengue disease around defervescence,” International Journal of Infectious Diseases, vol. 18, pp. 68–72, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. P. Montuschi, “Isoprostanes: markers and mediators of oxidative stress,” The FASEB Journal, vol. 18, no. 15, pp. 1791–1800, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. J. W. Stephens, M. P. Khanolkar, and S. C. Bain, “The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease,” Atherosclerosis, vol. 202, no. 2, pp. 321–329, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. C. Feillet-Coudray, F. Choné, F. Michel et al., “Divergence in plasmatic and urinary isoprostane levels in type 2 diabetes,” Clinica Chimica Acta, vol. 324, no. 1-2, pp. 25–30, 2002. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Mezzetti, “Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm,” Cardiovascular Research, vol. 47, no. 3, pp. 475–488, 2000. View at Publisher · View at Google Scholar · View at Scopus
  56. R. Nie, R. Xia, X. Zhong, and Z. Xia, “Salvia miltiorrhiza treatment during early reperfusion reduced postischemic myocardial injury in the rat,” Canadian Journal of Physiology and Pharmacology, vol. 85, no. 10, pp. 1012–1019, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. Q. Liu, J. Li, J. Wang, J. Li, J. S. Janicki, and D. Fan, “Effects and mechanisms of Chinese herbal medicine in ameliorating myocardial ischemia-reperfusion injury,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 925625, 14 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. N. G. Abraham and A. Kappas, “Pharmacological and clinical aspects of heme oxygenase,” Pharmacological Reviews, vol. 60, no. 1, pp. 79–127, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. T. Kawakami, N. Puri, K. Sodhi et al., “Reciprocal effects of oxidative stress on heme oxygenase expression and activity contributes to reno-vascular abnormalities in EC-SOD knockout mice,” International Journal of Hypertension, vol. 2012, Article ID 740203, 11 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. D. H. Kim, L. Vanella, K. Inoue et al., “Epoxyeicosatrienoic acid agonist regulates human mesenchymal stem cell–derived adipocytes through activation of HO-1-pAKT signaling and a decrease in PPARγ,” Stem Cells and Development, vol. 19, no. 12, pp. 1863–1873, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. R. Olszanecki, R. Rezzani, S. Omura et al., “Genetic suppression of HO-1 exacerbates renal damage: reversed by an increase in the antiapoptotic signaling pathway,” American Journal of Physiology-Renal Physiology, vol. 292, no. 1, pp. F148–F157, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. M. Salinas, R. Diaz, N. G. Abraham, C. M. R. de Galarreta, and A. Cuadrado, “Nerve growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner,” Journal of Biological Chemistry, vol. 278, no. 16, pp. 13898–13904, 2003. View at Publisher · View at Google Scholar · View at Scopus
  63. M. A. M. Ali, G. H. Heeba, and A. A. K. El-Sheikh, “Modulation of heme oxygenase-1 expression and activity affects streptozotocin-induced diabetic nephropathy in rats,” Fundamental & Clinical Pharmacology, vol. 31, no. 5, pp. 546–557, 2017. View at Publisher · View at Google Scholar